Cargando…

Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data

Nitrogen mustard is a chemotherapeutic agent that has a well-documented safety and efficacy profile in the treatment of cutaneous T-cell lymphoma. Development of nitrogen mustard formulations and treatment regimens has been studied extensively over the last 40 years. In the last 5 years, a new gel f...

Descripción completa

Detalles Bibliográficos
Autores principales: Liner, Kendall, Brown, Celeste, McGirt, Laura Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798535/
https://www.ncbi.nlm.nih.gov/pubmed/29440874
http://dx.doi.org/10.2147/DDDT.S137106
_version_ 1783297857635221504
author Liner, Kendall
Brown, Celeste
McGirt, Laura Y
author_facet Liner, Kendall
Brown, Celeste
McGirt, Laura Y
author_sort Liner, Kendall
collection PubMed
description Nitrogen mustard is a chemotherapeutic agent that has a well-documented safety and efficacy profile in the treatment of cutaneous T-cell lymphoma. Development of nitrogen mustard formulations and treatment regimens has been studied extensively over the last 40 years. In the last 5 years, a new gel formulation has been developed that is associated with a decrease in delayed hypersensitivity reactions. The authors in this review found that while the gel formulation may result in a decrease of allergic contact dermatitis, this advantage has been replaced by a higher number of irritant contact reactions and a decrease in complete response rate. The gel formulation has a complete response rate of 13.8%, which is a decrease in efficacy when compared to aqueous-based preparations of similar concentrations.
format Online
Article
Text
id pubmed-5798535
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-57985352018-02-13 Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data Liner, Kendall Brown, Celeste McGirt, Laura Y Drug Des Devel Ther Review Nitrogen mustard is a chemotherapeutic agent that has a well-documented safety and efficacy profile in the treatment of cutaneous T-cell lymphoma. Development of nitrogen mustard formulations and treatment regimens has been studied extensively over the last 40 years. In the last 5 years, a new gel formulation has been developed that is associated with a decrease in delayed hypersensitivity reactions. The authors in this review found that while the gel formulation may result in a decrease of allergic contact dermatitis, this advantage has been replaced by a higher number of irritant contact reactions and a decrease in complete response rate. The gel formulation has a complete response rate of 13.8%, which is a decrease in efficacy when compared to aqueous-based preparations of similar concentrations. Dove Medical Press 2018-01-31 /pmc/articles/PMC5798535/ /pubmed/29440874 http://dx.doi.org/10.2147/DDDT.S137106 Text en © 2018 Liner et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Liner, Kendall
Brown, Celeste
McGirt, Laura Y
Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data
title Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data
title_full Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data
title_fullStr Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data
title_full_unstemmed Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data
title_short Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data
title_sort clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous t-cell lymphoma: a review on current efficacy and safety data
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798535/
https://www.ncbi.nlm.nih.gov/pubmed/29440874
http://dx.doi.org/10.2147/DDDT.S137106
work_keys_str_mv AT linerkendall clinicalpotentialofmechlorethaminegelforthetopicaltreatmentofmycosisfungoidestypecutaneoustcelllymphomaareviewoncurrentefficacyandsafetydata
AT brownceleste clinicalpotentialofmechlorethaminegelforthetopicaltreatmentofmycosisfungoidestypecutaneoustcelllymphomaareviewoncurrentefficacyandsafetydata
AT mcgirtlauray clinicalpotentialofmechlorethaminegelforthetopicaltreatmentofmycosisfungoidestypecutaneoustcelllymphomaareviewoncurrentefficacyandsafetydata